Clinical Trial Update: Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension [Phase 3]

View source ↗

Summary

Open-label extension trial update for Lorundrostat in hypertension (Phase 3) to assess safety, efficacy, and tolerability; status shows Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Lorundrostat (lorundrostat)

Snippet

Sponsor: Mineralys Therapeutics Inc. | Conditions: Hypertension | Phase 3 | Status: ACTIVE_NOT_RECRUITING